These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 33786862

  • 1. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J.
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [Abstract] [Full Text] [Related]

  • 2. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [Abstract] [Full Text] [Related]

  • 3. The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis.
    Pan Y, Guo R, Lv Y, Cui D, Xie J.
    Can J Gastroenterol Hepatol; 2022 Aug; 2022():9035971. PubMed ID: 35360443
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [Abstract] [Full Text] [Related]

  • 5. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA, Kuo YF, Asrani S, Wong RJ, Ahmed A, Kwo P, Terrault N, Kamath PS, Jalan R, Singal AK.
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [Abstract] [Full Text] [Related]

  • 6. Von-Willebrand factor as a predictor of three-month mortality in patients with liver cirrhosis compared to MELD score.
    Curakova Ristovska E, Genadieva-Dimitrova M, Caloska-Ivanova V, Misevski J.
    Acta Gastroenterol Belg; 2019 Jun; 82(4):487-493. PubMed ID: 31950803
    [Abstract] [Full Text] [Related]

  • 7. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
    Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, Ay C, Quehenberger P, Fritzer-Szekeres M, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferlitsch A, Vienna Hepatic Hemodynamic Lab.
    Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193
    [Abstract] [Full Text] [Related]

  • 8. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group.
    Clin Transplant; 2012 Apr; 26(4):E395-401. PubMed ID: 22882694
    [Abstract] [Full Text] [Related]

  • 9. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP.
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [Abstract] [Full Text] [Related]

  • 10. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.
    Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S.
    Clin Nutr; 2020 Jun; 39(6):1885-1892. PubMed ID: 31481263
    [Abstract] [Full Text] [Related]

  • 11. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada.
    Burak KW, Meeberg GA, Myers RP, Fick GH, Swain MG, Bain VG, Kneteman NM, Hilsden RJ.
    Can J Gastroenterol Hepatol; 2016 Jun; 2016():1329532. PubMed ID: 27446823
    [Abstract] [Full Text] [Related]

  • 12. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW.
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [Abstract] [Full Text] [Related]

  • 13. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH, Ng CH, Tan D, Tseng M, Xiao J, Yong JN, Zeng RW, Cho E, Tay P, Ang CZ, Koh JH, Teng M, Syn N, Kow A, Huang DQ, Tan EX, Rinella ME, Sanyal A, Muthiah M, Siddiqui MS.
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [Abstract] [Full Text] [Related]

  • 14. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [Abstract] [Full Text] [Related]

  • 15. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.
    Remmler J, Schneider C, Treuner-Kaueroff T, Bartels M, Seehofer D, Scholz M, Berg T, Kaiser T.
    Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544
    [Abstract] [Full Text] [Related]

  • 19. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D.
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [Abstract] [Full Text] [Related]

  • 20. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M.
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.